Housset C - Search Results

1

Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease.

Fedchuk L, Nascimbeni F, Pais R, Charlotte F, Housset C, Ratziu V; LIDO Study Group. Fedchuk L, et al. Among authors: housset c. Aliment Pharmacol Ther. 2014 Nov;40(10):1209-22. doi: 10.1111/apt.12963. Epub 2014 Sep 29. Aliment Pharmacol Ther. 2014. PMID: 25267215 Free article.

2

Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.

Lemoine M, Ratziu V, Kim M, Maachi M, Wendum D, Paye F, Bastard JP, Poupon R, Housset C, Capeau J, Serfaty L. Lemoine M, et al. Among authors: housset c. Liver Int. 2009 Oct;29(9):1431-8. doi: 10.1111/j.1478-3231.2009.02022.x. Epub 2009 Apr 24. Liver Int. 2009. PMID: 19422483

3

Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age.

Poynard T, Munteanu M, Deckmyn O, Ngo Y, Drane F, Messous D, Castille JM, Housset C, Ratziu V, Imbert-Bismut F. Poynard T, et al. Among authors: housset c. BMC Gastroenterol. 2011 Apr 14;11:39. doi: 10.1186/1471-230X-11-39. BMC Gastroenterol. 2011. PMID: 21492460 Free PMC article.

4

The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans.

Benhamed F, Denechaud PD, Lemoine M, Robichon C, Moldes M, Bertrand-Michel J, Ratziu V, Serfaty L, Housset C, Capeau J, Girard J, Guillou H, Postic C. Benhamed F, et al. Among authors: housset c. J Clin Invest. 2012 Jun;122(6):2176-94. doi: 10.1172/JCI41636. Epub 2012 May 1. J Clin Invest. 2012. PMID: 22546860 Free PMC article. Clinical Trial.

5

Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: proof of concept and first application in a large population.

Poynard T, Munteanu M, Deckmyn O, Ngo Y, Drane F, Castille JM, Housset C, Ratziu V, Imbert-Bismut F. Poynard T, et al. Among authors: housset c. J Hepatol. 2012 Sep;57(3):541-8. doi: 10.1016/j.jhep.2012.04.025. Epub 2012 May 18. J Hepatol. 2012. PMID: 22612998

6

Portal myofibroblasts promote vascular remodeling underlying cirrhosis formation through the release of microparticles.

Lemoinne S, Cadoret A, Rautou PE, El Mourabit H, Ratziu V, Corpechot C, Rey C, Bosselut N, Barbu V, Wendum D, Feldmann G, Boulanger C, Henegar C, Housset C, Thabut D. Lemoinne S, et al. Among authors: housset c. Hepatology. 2015 Mar;61(3):1041-55. doi: 10.1002/hep.27318. Epub 2015 Jan 22. Hepatology. 2015. PMID: 25043701

7

Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemia.

Perazzo H, Munteanu M, Ngo Y, Lebray P, Seurat N, Rutka F, Couteau M, Jacqueminet S, Giral P, Monneret D, Imbert-Bismut F, Ratziu V, Hartemann-Huertier A, Housset C, Poynard T; FLIP Consortium. Perazzo H, et al. Among authors: housset c. Aliment Pharmacol Ther. 2014 Nov;40(9):1081-93. doi: 10.1111/apt.12946. Epub 2014 Sep 3. Aliment Pharmacol Ther. 2014. PMID: 25186086 Free article.

8

Awareness of the severity of liver disease re-examined using software-combined biomarkers of liver fibrosis and necroinflammatory activity.

Poynard T, Deckmyn O, Munteanu M, Ngo Y, Drane F, Castille JM, Housset C, Ratziu V; FIBROFRANCE Group. Poynard T, et al. Among authors: housset c. BMJ Open. 2015 Dec 23;5(12):e010017. doi: 10.1136/bmjopen-2015-010017. BMJ Open. 2015. PMID: 26700292 Free PMC article.

9

Fatty liver is an independent predictor of early carotid atherosclerosis.

Pais R, Giral P, Khan JF, Rosenbaum D, Housset C, Poynard T, Ratziu V; LIDO Study Group. Pais R, et al. Among authors: housset c. J Hepatol. 2016 Jul;65(1):95-102. doi: 10.1016/j.jhep.2016.02.023. Epub 2016 Apr 26. J Hepatol. 2016. PMID: 27129836

10

Long-term prognostic value of the FibroTest in patients with non-alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease.

Munteanu M, Pais R, Peta V, Deckmyn O, Moussalli J, Ngo Y, Rudler M, Lebray P, Charlotte F, Thibault V, Lucidarme O, Ngo A, Imbert-Bismut F, Housset C, Thabut D, Ratziu V, Poynard T; FibroFrance Group. Munteanu M, et al. Among authors: housset c. Aliment Pharmacol Ther. 2018 Nov;48(10):1117-1127. doi: 10.1111/apt.14990. Epub 2018 Oct 17. Aliment Pharmacol Ther. 2018. PMID: 30334263 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

202 results

Search Page